MX2016000345A - Vector aav y ensayo para anticuerpos neutralizantes anti-aav (virus adenoasociado). - Google Patents
Vector aav y ensayo para anticuerpos neutralizantes anti-aav (virus adenoasociado).Info
- Publication number
- MX2016000345A MX2016000345A MX2016000345A MX2016000345A MX2016000345A MX 2016000345 A MX2016000345 A MX 2016000345A MX 2016000345 A MX2016000345 A MX 2016000345A MX 2016000345 A MX2016000345 A MX 2016000345A MX 2016000345 A MX2016000345 A MX 2016000345A
- Authority
- MX
- Mexico
- Prior art keywords
- aav
- associated viruses
- test
- methods
- neutralizing antibodies
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14131—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/075—Adenoviridae
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/90241—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Tropical Medicine & Parasitology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361845841P | 2013-07-12 | 2013-07-12 | |
| PCT/US2014/046428 WO2015006743A1 (en) | 2013-07-12 | 2014-07-11 | Aav vector and assay for anti-aav (adeno-associated virus) neutralizing antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016000345A true MX2016000345A (es) | 2016-06-21 |
Family
ID=52280652
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016000345A MX2016000345A (es) | 2013-07-12 | 2014-07-11 | Vector aav y ensayo para anticuerpos neutralizantes anti-aav (virus adenoasociado). |
| MX2021000675A MX2021000675A (es) | 2013-07-12 | 2016-01-11 | Vector aav y ensayo para anticuerpos neutralizantes anti-aav (virus adenoasociado). |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021000675A MX2021000675A (es) | 2013-07-12 | 2016-01-11 | Vector aav y ensayo para anticuerpos neutralizantes anti-aav (virus adenoasociado). |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11408899B2 (https=) |
| EP (2) | EP4039813A1 (https=) |
| JP (4) | JP2016525347A (https=) |
| KR (1) | KR102445330B1 (https=) |
| CN (2) | CN105518145A (https=) |
| AU (1) | AU2014287005C1 (https=) |
| CA (1) | CA2918038C (https=) |
| HK (1) | HK1222673A1 (https=) |
| IL (1) | IL243438B (https=) |
| MX (2) | MX2016000345A (https=) |
| RU (1) | RU2705249C2 (https=) |
| WO (1) | WO2015006743A1 (https=) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016164920A1 (en) * | 2015-04-09 | 2016-10-13 | Cornell University | Gene therapy to prevent reactions to allergens |
| WO2016210170A1 (en) | 2015-06-23 | 2016-12-29 | The Children's Hospital Of Philadelphia | Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues |
| RU2021102893A (ru) | 2015-11-05 | 2021-03-03 | Бамбу Терапьютикс, Инк. | Модифицированные гены атаксии фридрейха и векторы для генной терапии |
| WO2017096162A1 (en) * | 2015-12-02 | 2017-06-08 | Voyager Therapeutics, Inc. | Assays for the detection of aav neutralizing antibodies |
| WO2019006418A2 (en) | 2017-06-30 | 2019-01-03 | Intima Bioscience, Inc. | ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY |
| US20210228738A1 (en) * | 2017-07-17 | 2021-07-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins |
| CN107828821A (zh) * | 2017-11-15 | 2018-03-23 | 四川大学 | 一种腺相关病毒感染敏感的细胞系的构建方法及腺相关病毒中和抗体含量测定的检测方法 |
| CA3086046C (en) * | 2017-12-29 | 2023-02-21 | Helixmith Co., Ltd. | Adeno-associated virus (aav) vector having hybrid hgf gene introduced thereto |
| CN111902164A (zh) | 2018-02-01 | 2020-11-06 | 同源药物公司 | 用于恢复pah基因功能的腺相关病毒组合物及其使用方法 |
| US10610606B2 (en) | 2018-02-01 | 2020-04-07 | Homology Medicines, Inc. | Adeno-associated virus compositions for PAH gene transfer and methods of use thereof |
| CN112041437A (zh) | 2018-02-19 | 2020-12-04 | 同源药物公司 | 用于恢复f8基因功能的腺相关病毒组合物和其使用方法 |
| EP3775173A1 (en) * | 2018-04-05 | 2021-02-17 | Genethon | Hybrid recombinant adeno-associated virus serotype between aav9 and aavrh74 with reduced liver tropism |
| EP3796980A4 (en) * | 2018-05-22 | 2022-03-23 | The Brigham & Women's Hospital, Inc. | NEW THERAPY FOR ALZHEIMER'S DISEASE |
| CN110846392A (zh) * | 2018-08-20 | 2020-02-28 | 武汉纽福斯生物科技有限公司 | 一种重组腺相关病毒或含其的试剂盒及其应用 |
| MX2021005727A (es) * | 2018-11-16 | 2021-09-10 | Spark Therapeutics Inc | Ensayo in vitro para detectar potenciadores e inhibidores de la transducción de vectores virales adenoasociados (aav) y/o para detectar o cuantificar anticuerpos de unión anti-aav. |
| EP3918308A4 (en) * | 2019-01-31 | 2023-09-27 | Precision Bioservices, Inc. | METHOD FOR DETECTING AND CHARACTERIZING ANTIVIRAL VECTOR ANTIBODIES |
| AU2020263757B2 (en) | 2019-04-24 | 2025-08-28 | Takara Bio Inc. | AAV mutant having brain-targeting property |
| WO2020242892A1 (en) | 2019-05-24 | 2020-12-03 | The Brigham And Women's Hospital, Inc. | Gene therapy for alzheimer's disease |
| IL293285A (en) | 2019-11-29 | 2022-07-01 | Paros Bio Inc | Gene therapy for neurodegenerative disorders |
| TW202140791A (zh) | 2020-01-13 | 2021-11-01 | 美商霍蒙拉奇醫藥公司 | 治療苯酮尿症之方法 |
| KR20220133969A (ko) | 2020-01-28 | 2022-10-05 | 프리라인 테라퓨틱스 리미티드 | 바이러스 벡터에 대한 중화 항체 역가를 결정하기 위한 개선된 분석법 |
| WO2021209275A1 (en) * | 2020-04-12 | 2021-10-21 | Novoscope Ip Limited | Particles, dna & rna |
| TW202208632A (zh) | 2020-05-27 | 2022-03-01 | 美商同源醫藥公司 | 用於恢復ｐａｈ基因功能的腺相關病毒組成物及其使用方法 |
| PL4211231T3 (pl) * | 2020-09-10 | 2024-11-04 | Genethon | Kapsyd AAV modyfikowany peptydem |
| CN112143712B (zh) * | 2020-09-30 | 2022-11-01 | 中国科学院深圳先进技术研究院 | 一种重组腺相关病毒及其制备方法和在抗体检测的应用 |
| WO2023114816A1 (en) | 2021-12-14 | 2023-06-22 | Neurogene, Inc. | Recombinant optimized galc constructs and methods for treating galc-associated disorders |
| CN114277090A (zh) * | 2021-12-17 | 2022-04-05 | 宁波熙宁检测技术有限公司 | Aav8中和抗体检测方法和检测试剂盒 |
| GB202201242D0 (en) | 2022-01-31 | 2022-03-16 | Univ Edinburgh | Recombinant optimized mecp2 cassettes and methods for treating rett syndrome and related disorders |
| WO2023207918A1 (en) * | 2022-04-25 | 2023-11-02 | Beijing Hanmoluojie Technology Co., Ltd. | Aav capsid 3d molecular surface feature mapping |
| GB202206336D0 (en) | 2022-04-29 | 2022-06-15 | Univ Edinburgh | Recombinant therapeutic FMR1 constructs and methods of treating fragile X syndrome and related disorders |
| CN119562959A (zh) * | 2022-05-13 | 2025-03-04 | 费城儿童医院 | 用于靶向脑微脉管系统的腺相关病毒载体 |
| EP4536862A1 (en) * | 2022-06-09 | 2025-04-16 | Wisconsin Alumni Research Foundation | Generation of next generation recombinant aav gene therapy vectors that adopt 3d conformation |
| CN115047188A (zh) * | 2022-06-10 | 2022-09-13 | 上海鼎新基因科技有限公司 | 一种抗腺相关病毒中和抗体的检测方法 |
| CN117802161A (zh) * | 2022-06-30 | 2024-04-02 | 苏州吉恒基因科技有限公司 | 精准重组腺相关病毒载体及其用途 |
| US20250352580A1 (en) * | 2022-11-04 | 2025-11-20 | The Children's Hospital Of Philadelphia | Compositions and methods for b cell directed immunotherapies for anti-aav neutralizing alloantibodies |
| CN117285620B (zh) * | 2023-11-27 | 2024-02-13 | 恺佧生物科技(上海)有限公司 | 抗aav9抗体及aav9滴度测定elisa试剂盒 |
| WO2025119252A1 (en) * | 2023-12-06 | 2025-06-12 | Immvira Biopharmaceuticals Co., Limited | Methods for detecting an anti-hsv antibody in a sample |
| WO2026017965A1 (en) | 2024-07-19 | 2026-01-22 | The University Court Of The University Of Edinburgh | Recombinant therapeutic fxn constructs and methods of treating friedreich ataxia and related conditions |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU722624B2 (en) | 1996-09-06 | 2000-08-10 | Trustees Of The University Of Pennsylvania, The | An inducible method for production of recombinant adeno-associated viruses utilizing T7 polymerase |
| DE69841982D1 (de) * | 1997-03-14 | 2010-12-16 | Philadelphia Children Hospital | Zusammensetzungen zum einsatz in einer gentherapie zur behandlung von hämophilie |
| JP4025400B2 (ja) * | 1997-04-16 | 2007-12-19 | 財団法人化学及血清療法研究所 | 新規免疫制御分子及びその製造方法 |
| EP1082413B1 (en) * | 1998-05-28 | 2008-07-23 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Aav5 vector and uses thereof |
| CA2349838C (en) | 1998-11-05 | 2011-06-07 | The Trustees Of The University Of Pennsylvania | Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| US6759237B1 (en) | 1998-11-05 | 2004-07-06 | The Trustees Of The University Of Pennsylvania | Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| DK1035133T3 (da) * | 1999-02-17 | 2005-05-02 | Pfizer Prod Inc | Fusionsproteiner, der omfatter bærere, som kan inducere et dobbelt immunrespons |
| EP1222299A1 (en) * | 1999-10-01 | 2002-07-17 | Genovo, Incorporated | Production of recombinant aav using adenovirus comprising aav rep/cap genes |
| US7241447B1 (en) * | 1999-10-07 | 2007-07-10 | University Of Iowa Research Foundation | Adeno-associated virus vectors and uses thereof |
| NZ522840A (en) * | 2000-06-01 | 2004-12-24 | Univ North Carolina | A parvovirus vector that carries a duplexed genome resulting in co-packaging of strands of plus and minus polarity tethered together |
| DE50304957D1 (de) * | 2002-04-15 | 2006-10-19 | Universitaetsklinikum Hamburg | Rekombinante virale vektoren zur tetracyclinregulierbaren genexpression |
| EP1369491A1 (en) | 2002-06-05 | 2003-12-10 | Aladar A. Szalay | Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| AU2003274397A1 (en) * | 2002-06-05 | 2003-12-22 | University Of Florida | Production of pseudotyped recombinant aav virions |
| KR20050010916A (ko) | 2002-06-13 | 2005-01-28 | 와이어쓰 홀딩스 코포레이션 | 염증 유전자 활성 및 콜레스테롤 생합성의 억제제 |
| JP2012503771A (ja) * | 2008-09-25 | 2012-02-09 | デューク ユニバーシティー | 抗体および抗体−ｈｉｖビリオン複合体を検出する方法 |
| JP5879256B2 (ja) | 2009-05-02 | 2016-03-08 | ジェンザイム・コーポレーション | 神経変性障害のための遺伝子治療 |
| CN103167896B (zh) * | 2010-08-20 | 2015-12-16 | 耐克创新有限合伙公司 | 高尔夫球杆和高尔夫球杆头 |
| JP4916596B1 (ja) | 2010-10-01 | 2012-04-11 | パナソニック株式会社 | 脂質二重膜の表側から裏側にカリウムイオンを輸送する方法 |
| US8202687B2 (en) | 2010-10-01 | 2012-06-19 | Panasonic Corporation | Method for transporting potassium ions from front side to back side of lipid bilayer membrane |
| SG10202103336SA (en) | 2010-11-02 | 2021-04-29 | Promega Corp | Novel coelenterazine substrates and methods of use |
| ES2685611T3 (es) * | 2011-02-14 | 2018-10-10 | The Children's Hospital Of Philadelphia | Vector VAA8 mejorado con una actividad funcional aumentada y métodos de utilización del mismo |
| CN103014064A (zh) | 2011-09-22 | 2013-04-03 | 北京五加和分子医学研究所有限公司 | Itr同向排列的aav载体构建及其应用 |
| JP6348064B2 (ja) * | 2011-11-22 | 2018-06-27 | ザ チルドレンズ ホスピタル オブ フィラデルフィア | 効率の高いトランスジーン送達のためのウイルスベクター |
-
2014
- 2014-07-11 HK HK16110663.7A patent/HK1222673A1/zh unknown
- 2014-07-11 CA CA2918038A patent/CA2918038C/en active Active
- 2014-07-11 MX MX2016000345A patent/MX2016000345A/es unknown
- 2014-07-11 CN CN201480039270.1A patent/CN105518145A/zh active Pending
- 2014-07-11 US US14/904,205 patent/US11408899B2/en active Active
- 2014-07-11 RU RU2016104614A patent/RU2705249C2/ru not_active Application Discontinuation
- 2014-07-11 EP EP21209775.2A patent/EP4039813A1/en active Pending
- 2014-07-11 CN CN202310061410.6A patent/CN116004721A/zh active Pending
- 2014-07-11 EP EP14823769.6A patent/EP3019620A4/en not_active Withdrawn
- 2014-07-11 KR KR1020167003572A patent/KR102445330B1/ko active Active
- 2014-07-11 JP JP2016525827A patent/JP2016525347A/ja active Pending
- 2014-07-11 WO PCT/US2014/046428 patent/WO2015006743A1/en not_active Ceased
- 2014-07-11 AU AU2014287005A patent/AU2014287005C1/en active Active
-
2015
- 2015-12-31 IL IL243438A patent/IL243438B/en active IP Right Grant
-
2016
- 2016-01-11 MX MX2021000675A patent/MX2021000675A/es unknown
-
2019
- 2019-04-04 JP JP2019072287A patent/JP2019162109A/ja active Pending
-
2021
- 2021-12-02 JP JP2021195840A patent/JP2022037027A/ja active Pending
-
2022
- 2022-06-30 US US17/855,571 patent/US20220334126A1/en not_active Abandoned
-
2023
- 2023-12-01 JP JP2023204220A patent/JP2024026253A/ja active Pending
-
2025
- 2025-10-24 US US19/368,502 patent/US20260043810A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014287005A1 (en) | 2016-01-28 |
| EP4039813A1 (en) | 2022-08-10 |
| EP3019620A1 (en) | 2016-05-18 |
| RU2016104614A3 (https=) | 2018-03-05 |
| KR102445330B1 (ko) | 2022-09-19 |
| US20160123990A1 (en) | 2016-05-05 |
| JP2019162109A (ja) | 2019-09-26 |
| JP2022037027A (ja) | 2022-03-08 |
| US20260043810A1 (en) | 2026-02-12 |
| KR20160034332A (ko) | 2016-03-29 |
| CA2918038C (en) | 2023-03-28 |
| US20220334126A1 (en) | 2022-10-20 |
| JP2016525347A (ja) | 2016-08-25 |
| CA2918038A1 (en) | 2015-01-15 |
| US11408899B2 (en) | 2022-08-09 |
| IL243438B (en) | 2020-02-27 |
| RU2705249C2 (ru) | 2019-11-06 |
| AU2014287005C1 (en) | 2021-06-03 |
| WO2015006743A1 (en) | 2015-01-15 |
| HK1222673A1 (zh) | 2017-07-07 |
| MX2021000675A (es) | 2021-03-25 |
| AU2014287005B2 (en) | 2020-12-17 |
| RU2016104614A (ru) | 2017-08-18 |
| JP2024026253A (ja) | 2024-02-28 |
| EP3019620A4 (en) | 2017-01-18 |
| CN105518145A (zh) | 2016-04-20 |
| CN116004721A (zh) | 2023-04-25 |
| IL243438A0 (en) | 2016-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016000345A (es) | Vector aav y ensayo para anticuerpos neutralizantes anti-aav (virus adenoasociado). | |
| CL2018001611A1 (es) | Adenovirus del grupo b que codifica un anticuerpo o fragmento anti-tcr-complejo | |
| CL2016002840A1 (es) | Composiciones que comprenden aav que expresa constructos de anticuerpos duales y sus usos | |
| ZA202101002B (en) | Methods for detecting aav | |
| EP2871239A4 (en) | CELL FOR THE PRODUCTION OF AN ADENO-ASSOCIATED VIRUS VECTOR | |
| EP3387137A4 (en) | TARGET PEPTIDES FOR LEADING ADENO ASSOCIATED VIRUSES (AAVS) | |
| MX2019008736A (es) | Anticuerpos anti-virus del dengue y usos de los mismos. | |
| EP3891290A4 (en) | ADENO-ASSOCIATED VIRUS (AAV) PRODUCING CELL LINE AND METHODS | |
| CR20180480A (es) | Receptores quiméricos y métodos de uso de los mismos | |
| NI201500103A (es) | Anticuerpos cd47 que no agotan plaquetas ni glóbulos rojos y métodos de uso de los mismos. | |
| EA201990937A1 (ru) | Цитомегаловирусные векторы, выбирающие t-клетки, ограниченные по молекулам главного комплекса гистосовместимости e | |
| MX386802B (es) | Vectores del factor viii del virus adeno-asociado. | |
| WO2014015194A3 (en) | Methods for detecting and measuring aggregation | |
| EP3296718A4 (en) | STATION USED FOR TEST APPARATUS WITH INTEGRATED REACTION AND DETECTION MEANS | |
| BR112014028600A2 (pt) | formulações de anticorpo monoclonal de alta concentração | |
| BR112016016916A8 (pt) | uso de um anticorpo que se liga à calicreína plasmática ativa para tratamento de angiodema hereditário (hae) | |
| DK3083970T3 (da) | Fremgangsmåde til oprensning af kappebærende virusser eller virale vektorer | |
| MX375701B (es) | Ensayos para igfbp7 con mejor rendimiento en muestras biológicas. | |
| MX2021005727A (es) | Ensayo in vitro para detectar potenciadores e inhibidores de la transducción de vectores virales adenoasociados (aav) y/o para detectar o cuantificar anticuerpos de unión anti-aav. | |
| TR201819828T4 (tr) | Anti-fosfolipaz d4 antikoru. | |
| MX378905B (es) | Pestivirus. | |
| EA201991506A1 (ru) | Системы и способы для тестирования и скрининга с использованием связанных с соединениями субстратов | |
| EP3452504A4 (en) | MONOCLONAL DNA ANTIBODIES TARGETING INFLUENZA VIRUS | |
| EP3563869A4 (en) | PHARMACEUTICAL PREPARATION CONSISTING OF A CD147 MONOCLONAL ANTIBODY | |
| EP3751000C0 (en) | IMPROVED ADENO-ASSOCIATED VIRAL VECTOR |